Homepage > Company > Media > Pharma News > 2017 > New review examines link between psoriasis and psychiatric illnesses

New review examines link between psoriasis and psychiatric illnesses

A new review examines the potential link between psoriasis and mental health conditions.

Psoriasis can be a socially isolating disease due to debilitating physical symptoms and the stigma patients feel because of the appearance of their skin. Anxiety, depression, and suicidal ideation and behavior are prevalent in these individuals.

Evidence suggests that inflammatory molecules—such as interleukin 1 and interleukin 6, which are elevated in both psoriasis and depression—may underlie the relationship between psoriasis and mental health comorbidities.

The review is published in the Journal of the European Academy of Dermatology and Venereology.

Source:

http://wiley.newshq.businesswire.com/press-release/journal-european-academy-dermatology-and-venereology/psoriasis-and-psychiatric-illness

August 11, 2017

https://www.news-medical.net/

Read also

FDA warns vs fake versions of popular medicines

MANILA, Philippines - counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported. ...

Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and Drug Administration (FDA) has granted its device Brea...

Cognixion receives FDA Breakthrough Device Designation for assisted communication device

EMA to review CTIS transparency rules

Public consultation seeks the best methods for balancing transparency with confidentiality in the EU Clinical Trials Information System, says the European Medicines Agency. ...